A cosa servono le compresse di Ciproxin?
Sommario
- A cosa servono le compresse di Ciproxin?
- Can single-dose oral ciprofloxacin prophylaxis be used to treat meningococcal meningitis?
- How is standard care provided in villages with meningitis?
- How many mg of ciprofloxacin do you give a 12 year old?
- What is the best strategy for meningococcus infection prevention?
![A cosa servono le compresse di Ciproxin?](https://i.ytimg.com/vi/SEJSlBLA_68/hqdefault.jpg?sqp=-oaymwEcCOADEI4CSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLDY383RYvsXgqez1ISMOBT_rGSgUQ)
A cosa servono le compresse di Ciproxin?
Ciproxin contiene il principio attivo ciprofloxacina. Ciproxin è un antibiotico appartenente alla famiglia dei fluorochinoloni. La ciprofloxacina agisce uccidendo i batteri che provocano le infezioni. Funziona solo con particolari ceppi di batteri.
Can single-dose oral ciprofloxacin prophylaxis be used to treat meningococcal meningitis?
- Single-dose oral ciprofloxacin prophylaxis as a response to a meningococcal meningitis epidemic in the African meningitis belt: A 3-arm, open-label, cluster-randomized trial. PLoS Med. 2018 Jun 26;15 (6):e1002593. doi: 10.1371/journal.pmed.1002593. eCollection 2018 Jun.
How is standard care provided in villages with meningitis?
- One third of enrolled villages will receive standard care; in one-third of villages, household contacts of meningitis cases will be offered a single dose of oral ciprofloxacin; and in one-third of villages, the entire village will be offered a single dose of oral ciprofloxacin after the notification of the first case in the village.
How many mg of ciprofloxacin do you give a 12 year old?
- Chemoprophylaxis with a single dose of oral ciprofloxacin for household members of reported cases of meningitis. For participants age >12 years: 500 mg tablet; age 5-12 years: 250 mg tablet; age 1-4 years: 125 mg tablet; age 3-11 months: 100 mg (2 ml oral suspension); age <3 months: 75 mg (1.5 ml oral suspension).
What is the best strategy for meningococcus infection prevention?
- Reactive vaccination campaigns are the preferred strategy for prevention during an epidemic. A novel strain of meningococcus, Neisseria meningitidis serogroup C (NmC), began circulating in Nigeria in 2013 and caused a major epidemic with over 10 000 cases in Nigeria and Niger in 2015.